Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

Background: Inhaled nitric oxide (iNO) has been studied in patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 when it may be too late to impact disease course. This article aims to describe real-world iNO use and outcomes in patients with COVID-19 with mild-to-moderate A...

Full description

Bibliographic Details
Main Authors: Steven H Abman, Nicholas R Fox, M Ibrahim Malik, Sneha S Kelkar, Shelby L Corman, Sanika Rege, Jenna Bhaloo, Rachel Shah, Ren-Jay Shei, Dana Saporito, Nisreen Shamseddine, Erik DeBoer, George J Wan, on behalf of the NOTICE Study Investigators
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2022-04-01
Series:Drugs in Context
Subjects:
acute respiratory distress syndrome (ards)
covid-19
inhaled nitric oxide
p/f ratio
real-world
Online Access:https://www.drugsincontext.com/real-world-use-of-inhaled-nitric-oxide-therapy-in-patients-with-covid-19-and-mild-to-moderate-acute-respiratory-distress-syndrome

Internet

https://www.drugsincontext.com/real-world-use-of-inhaled-nitric-oxide-therapy-in-patients-with-covid-19-and-mild-to-moderate-acute-respiratory-distress-syndrome

Similar Items